HOW BPH IS DIAGNOSED?
Your doctor will find out your medical history and conduct a physical examination that includes a finger examination of your prostate. During the examination, he uses his finger to understand the size, shape and hardness of the prostate.
Your symptoms will be carefully evaluated, blood and urine tests will be performed, and the speed of your urine flow will be measured with a uroflovmetry test.
What tests are done to diagnose a benign prostate?
– PSA test
– Urine test and urine culture
– Measurement of uroflovmetry
– Urine remaining after urination (PMR)
– Ultrasound examination of the bladder and prostate
“MAYO CLINIC Patient Care & Health Information Diseases & Conditions Benign prostatic hyperplasia (BPH)”
WHAT ARE THE TREATMENT OPTIONS?
Wait and See
Patients who choose to follow a waiting policy by observing it should be evaluated annually at the 6th month and after, provided that there is no increase in symptoms or absolute indications for surgical treatment do not develop.
* European Association, U., European Association of Urology Guidelines. 2020 Edition. Vol. presented at the EAU Annual Congress Amsterdam 2020. 2020, Arnhem, The Netherlands: European
Association of Urology Guidelines Office.
Pharmacological Products with Herbal Action
Herbal products can be used with other BPH treatment options, but each patient profile is different, please consult your doctor before making a decision. The use of herbal pharmacological products for the treatment of lower urinary tract symptoms and benign prostatic enlargement (BPH) has been one of the leading treatments in Europe for many years and has recently become widespread. Several short studies with some herbal agents, such as Serenoa repens, and some meta-analyses have shown that the compounds have clinical efficacy without causing significant side effects.
Crucial Advice to Help Reduce the Risk and Growth of BPH By: Mark A. Moyad, MD, MPH | Posted on: 23 Aug 2017
* Soo Liang Ooi et al., Serenoa repens for Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia: Current Evidence and its Clinical Implications in Naturopathic Medicine, THE JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE Volume 00, Number 00, 2017, pp. 1–8.
Alpha-Blocker Drug Therapy
In order to determine their response to treatment, patients should be re-examined after the first 6 weeks of treatment. If patients achieve symptomatic relief without unpleasant side effects, alpha-blocker therapy can be continued. 6. Patients, provided that there is no worsening of symptoms or the development of absolute indications for surgical treatment. they should be reevaluated monthly and then annually.
European Association, U., European Association of Urology Guidelines. 2020 Edition. Vol. presented at the EAU Annual Congress Amsterdam 2020. 2020, Arnhem, The Netherlands: European Association of Urology Guidelines Office.
Pharmacological Treatment with 5-Alpha-Reductase Inhibitors
In order to determine their response to treatment, patients should be re-examined 12 weeks after the start of treatment and at the 6th month. Further evaluation is the same as in other drug therapy.
European Association, U., European Association of Urology Guidelines. 2020 Edition. Vol. presented at the EAU Annual Congress Amsterdam 2020. 2020, Arnhem, The Netherlands: European Association of Urology Guidelines Office
Surgical Treatment
Patients can be seen within 6 weeks after surgical treatment to discuss histological findings and detect early post-operative morbidity (Disease status after surgery). To determine the final result, long-term follow-up should be scheduled for the 3rd month. In patients with unsuccessful treatment, a urodynamic examination should be performed, which also includes a pressure-current analysis.”
* European Association, U., European Association of Urology Guidelines. 2020 Edition. Vol. presented at the EAU Annual Congress Amsterdam 2020. 2020, Arnhem, The Netherlands: European Association of
Urology Guidelines Office.
WHAT ARE THE TREATMENT OPTIONS?
Wait and See
Patients who choose to follow a waiting policy by observing it should be evaluated annually at the 6th month and after, provided that there is no increase in symptoms or absolute indications for surgical treatment do not develop.
* European Association, U., European Association of Urology Guidelines. 2020 Edition. Vol. presented at the EAU Annual Congress Amsterdam 2020. 2020, Arnhem, The Netherlands: European Association of Urology Guidelines Office.
Pharmacological Products with Herbal Action
Herbal products can be used with other BPH treatment options, but each patient profile is different, please consult your doctor before making a decision. The use of herbal pharmacological products for the treatment of lower urinary tract symptoms and benign prostatic enlargement (BPH) has been one of the leading treatments in Europe for many years and has recently become widespread. Several short studies with some herbal agents, such as Serenoa repens, and some meta-analyses have shown that the compounds have clinical efficacy without causing significant side effects.
Crucial Advice to Help Reduce the Risk and Growth of BPH By: Mark A. Moyad, MD, MPH | Posted on: 23 Aug 2017 * Soo Liang Ooi et al., Serenoa repens for Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia: Current Evidence and its Clinical Implications in Naturopathic Medicine, THE JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE Volume 00, Number 00, 2017, pp. 1–8.
Alpha-Blocker Drug Therapy
In order to determine their response to treatment, patients should be re-examined after the first 6 weeks of treatment. If patients achieve symptomatic relief without unpleasant side effects, alpha-blocker therapy can be continued. 6. Patients, provided that there is no worsening of symptoms or the development of absolute indications for surgical treatment. they should be reevaluated monthly and then annually.
European Association, U., European Association of Urology Guidelines. 2020 Edition. Vol. presented at the EAU Annual Congress Amsterdam 2020. 2020, Arnhem, The Netherlands: European Association of Urology Guidelines Office.
Pharmacological Treatment with 5-Alpha-Reductase Inhibitors
In order to determine their response to treatment, patients should be re-examined 12 weeks after the start of treatment and at the 6th month. Further evaluation is the same as in other drug therapy.
European Association, U., European Association of Urology Guidelines. 2020 Edition. Vol. presented at the EAU Annual Congress Amsterdam 2020. 2020, Arnhem, The Netherlands: European Association of Urology Guidelines Office
Surgical Treatment
Patients can be seen within 6 weeks after surgical treatment to discuss histological findings and detect early post-operative morbidity (Disease status after surgery). To determine the final result, long-term follow-up should be scheduled for the 3rd month. In patients with unsuccessful treatment, a urodynamic examination should be performed, which also includes a pressure-current analysis.”
* European Association, U., European Association of Urology Guidelines. 2020 Edition. Vol. presented at the EAU Annual Congress Amsterdam 2020. 2020, Arnhem, The Netherlands: European Association of Urology Guidelines Office.
Disurinorm® EFFECTIVE
Provides a holistic treatment support
Disurinorm® IS SAFE
Improves the patient's quality of life.
Disurinorm® IS EASILY USED
It is easily absorbed, and the effect begins quickly
Disurinorm® OFFERS TROUBLE-FREE LIVING
It takes control of the symptoms (signs, complaints)
